Skip to content

Drug interactions

Pazopanib + Solifenacin

Severity: Moderate

Pazopanib and Solifenacin: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can prolong the QT interval, so combined use may increase the risk of torsades de pointes, particularly with other risk factors. Pazopanib carries a labeled QT warning and solifenacin has dose-related QT effects.

What this interaction means in plain words

Pazopanib and Solifenacin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Pazopanib belongs to Oncology; Solifenacin belongs to Genitourinary.

Evidence level: Low

Why it happens

Additive prolongation of cardiac repolarization through effects on cardiac potassium channels.

What to do

Obtain a baseline ECG and monitor the QTc during therapy, and correct potassium and magnesium disturbances. Consider an alternative bladder antimuscarinic if the QTc becomes markedly prolonged.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Pazopanib and Solifenacin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Pazopanib with Solifenacin?

MediHelp rates the interaction as moderate. Pazopanib and Solifenacin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can prolong the QT interval, so combined use may increase the risk of torsades de pointes, particularly with other risk factors. Pazopanib carries a labeled QT warning and solifenacin has dose-related QT effects.

How serious is the interaction between Pazopanib and Solifenacin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor the QTc during therapy, and correct potassium and magnesium disturbances. Consider an alternative bladder antimuscarinic if the QTc becomes markedly prolonged.

What other medicines interact with Solifenacin?

MediHelp also lists interactions of Solifenacin with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Solifenacin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in